<DOC>
	<DOCNO>NCT03094819</DOCNO>
	<brief_summary>The PROTECT2 pilot study single cohort prospective study gather pilot data finalize operational detail main study . The PROTECT2 main study prospective randomize control multi-center three group clinical trial . The primary endpoint percentage participant study group obtain qualify eye examination within 12 month enrollment study .</brief_summary>
	<brief_title>PROTECT2 - See Official Title Response PRS Review Comments 1</brief_title>
	<detailed_description>The primary objective study compare qualify eye examination rate two group patient diabetes receive new intervention , rate control group patient diabetes receive usual care . Secondary objective : - Improve understanding barrier obtain eye examination ; - Evaluate communication eye care provider ( ECP ) refer primary care provider ( PCP ) , determine rate follow-up report send receive ; - Characterize eye examination provide patient diabetes ; - Explore relationship systemic variable know affect severity diabetic retinopathy patient 's risk vision-threatening diabetic retinopathy . Design Primary Endpoint - The pilot study single cohort prospective study gather pilot data finalize operational detail main study . - The main study prospective randomize control multi-center three group clinical trial . The primary endpoint percentage participant study group obtain qualify eye examination within 12 month enrollment study . Interventions Duration Eligible patient randomize one three group 1:1:2 ratio . - Group 1 . Participants randomize Group 1 control group . They observe receive usual eye care without study intervention . - Financial Incentive . Participants randomized Financial Incentive group offer financial incentive conjunction usual eye care . They receive usual care $ 25 payment obtain confirmed eye examination . - Retinal Care DR Service . Participants randomize Retinal Care DR Service group receive : ( 1 ) point care risk assessment vision- threatening diabetic retinopathy , ( 2 ) retinal specialist interpretation risk assessment data , ( 3 ) care coordination design improve eye examination rate patient diabetes increased risk vision- threaten diabetic retinopathy . All participant , regardless group , study one year . Sample Size Population Patients meet inclusion exclusion criterion recruit four ( 4 ) study sit sample size 4,500 participant enrol . This include 500 patient site pilot study , weight randomization main study ensure enrollment approximately 500 patient Retinal Care DR Service group site evaluate operational characteristic Retinal Care DR Service population representative anticipate commercial use .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>1 . Diagnosed diabetes use criterion documented 2016 Physician Quality Reporting System ( PQRS ) Measure Specifications Manual Claims Registry Reporting Individual Measures . 2 . 18 75 year age 3 . Have PCP appointment schedule within 90 day date medical record review . 1 . Patients diagnose diabetes 2 . History photosensitive epilepsy 3 . Inability unwillingness participant give verbal write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>